alexa Antivirulence Agents Sensitize MRSA To Beta-lactam Antibiotics
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Menachem Shoham
Accepted Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.008
Resistance to antibiotics has created a severe public health problem worldwide. Thus, the development of novel antibacterial agents represents an urgent unmet medical need. An alternative approach to antibiotics is the use of antivirulence agents. These compounds do not kill bacteria as antibiotics do but inhibit the production of disease-causing toxins and other virulence factors that impair the ability of the immune system to fight the infection. Prevention of virulence factor secretion would disarm the pathogen of its deadly chemical weapons. However, antivirulence agents do not kill the pathogen. Thus, an infection might recur if the treatment is stopped. Therefore, it might be beneficial in some cases to employ a combination therapy with an antibiotic. Experiments in our laboratory indicate a synergism with beta-lactam antibiotics to which MRSA is resistant in mono therapy. Antivirulence agents sensitize MRSA to beta-lactam antibiotics. This finding opens the door to combination therapy of an antivirulence drug with ?old? and inexpensive beta-lactam antibiotics. This approach has the potential to revolutionize the prevention and treatment of bacterial infections.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version